Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil

A study of 88 surgical specimens

Kentaro Yoshinare, Tetsuro Kubota, Masahiko Watanabe, Norihito Wada, Hideki Nishibori, Hirotoshi Hasegawa, Masaki Kitajima, Teiji Takechi, Msakazu Fukushima

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

To predict the sensitivity of colorectal cancer to 5-fluorouracil (5-FU), we compared the gene expression of surgically obtained colorectal cancer specimens with chemosensitivity to 5-FU as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay. Eighty-eight patients with advanced and/or metastatic colorectal cancer provided written informed consent and entered the trial from September 2000 to October 2001. Fresh surgical specimens were used for the MTT assay, and sensitivity to 5-FU was evaluated at a cutoff concentration of 50 μg/ml and 48-h incubation time. Frozen samples were stored at -80°C until mRNA analysis of thymidylate synthetase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP , esnucleoside transporter (NT), and E2F1 by real-time RT-PCR. The correlations between the variables were analyzed, and the predictive value of these mRNAs was assessed statistically using a receiver operating characteristic (ROC) curve. NT and DPD, TP and DPD, and TP and NT mRNA expression levels correlated significantly, while TS and E2F1 showed no correlations. High NT expression was associated with low sensitivity to 5-FU (P<0.013), as were high DPD and E2F1 expression (P<0.022 for both). High TP mRNA expression correlated with low sensitivity to 5-FU (P<0.034), although high TS mRNA expression did not. ROC curves indicated that DPD and NT mRNAs were possible predictors of sensitivity to 5-FU, with cutoff values of 0.6 and 0.4, respectively. The sensitivity of colorectal cancer to 5-FU may be regulated by DPD, the rate-limiting enzyme of catabolism, and NT, an important transmembrane transporter of nucleosides.

Original languageEnglish
Pages (from-to)633-638
Number of pages6
JournalCancer Science
Volume94
Issue number7
DOIs
Publication statusPublished - 2003 Jul 1

Fingerprint

Dihydrouracil Dehydrogenase (NADP)
Fluorouracil
Colorectal Neoplasms
Gene Expression
Thymidylate Synthase
Messenger RNA
ROC Curve
Nucleoside Transport Proteins
Thymidine Phosphorylase
In Vitro Techniques
Informed Consent
Real-Time Polymerase Chain Reaction
Enzymes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil : A study of 88 surgical specimens. / Yoshinare, Kentaro; Kubota, Tetsuro; Watanabe, Masahiko; Wada, Norihito; Nishibori, Hideki; Hasegawa, Hirotoshi; Kitajima, Masaki; Takechi, Teiji; Fukushima, Msakazu.

In: Cancer Science, Vol. 94, No. 7, 01.07.2003, p. 633-638.

Research output: Contribution to journalArticle

Yoshinare, K, Kubota, T, Watanabe, M, Wada, N, Nishibori, H, Hasegawa, H, Kitajima, M, Takechi, T & Fukushima, M 2003, 'Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: A study of 88 surgical specimens', Cancer Science, vol. 94, no. 7, pp. 633-638. https://doi.org/10.1111/j.1349-7006.2003.tb01495.x
Yoshinare, Kentaro ; Kubota, Tetsuro ; Watanabe, Masahiko ; Wada, Norihito ; Nishibori, Hideki ; Hasegawa, Hirotoshi ; Kitajima, Masaki ; Takechi, Teiji ; Fukushima, Msakazu. / Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil : A study of 88 surgical specimens. In: Cancer Science. 2003 ; Vol. 94, No. 7. pp. 633-638.
@article{2cc99f830a1341359b4b1e3c9df80f88,
title = "Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: A study of 88 surgical specimens",
abstract = "To predict the sensitivity of colorectal cancer to 5-fluorouracil (5-FU), we compared the gene expression of surgically obtained colorectal cancer specimens with chemosensitivity to 5-FU as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay. Eighty-eight patients with advanced and/or metastatic colorectal cancer provided written informed consent and entered the trial from September 2000 to October 2001. Fresh surgical specimens were used for the MTT assay, and sensitivity to 5-FU was evaluated at a cutoff concentration of 50 μg/ml and 48-h incubation time. Frozen samples were stored at -80°C until mRNA analysis of thymidylate synthetase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP , esnucleoside transporter (NT), and E2F1 by real-time RT-PCR. The correlations between the variables were analyzed, and the predictive value of these mRNAs was assessed statistically using a receiver operating characteristic (ROC) curve. NT and DPD, TP and DPD, and TP and NT mRNA expression levels correlated significantly, while TS and E2F1 showed no correlations. High NT expression was associated with low sensitivity to 5-FU (P<0.013), as were high DPD and E2F1 expression (P<0.022 for both). High TP mRNA expression correlated with low sensitivity to 5-FU (P<0.034), although high TS mRNA expression did not. ROC curves indicated that DPD and NT mRNAs were possible predictors of sensitivity to 5-FU, with cutoff values of 0.6 and 0.4, respectively. The sensitivity of colorectal cancer to 5-FU may be regulated by DPD, the rate-limiting enzyme of catabolism, and NT, an important transmembrane transporter of nucleosides.",
author = "Kentaro Yoshinare and Tetsuro Kubota and Masahiko Watanabe and Norihito Wada and Hideki Nishibori and Hirotoshi Hasegawa and Masaki Kitajima and Teiji Takechi and Msakazu Fukushima",
year = "2003",
month = "7",
day = "1",
doi = "10.1111/j.1349-7006.2003.tb01495.x",
language = "English",
volume = "94",
pages = "633--638",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil

T2 - A study of 88 surgical specimens

AU - Yoshinare, Kentaro

AU - Kubota, Tetsuro

AU - Watanabe, Masahiko

AU - Wada, Norihito

AU - Nishibori, Hideki

AU - Hasegawa, Hirotoshi

AU - Kitajima, Masaki

AU - Takechi, Teiji

AU - Fukushima, Msakazu

PY - 2003/7/1

Y1 - 2003/7/1

N2 - To predict the sensitivity of colorectal cancer to 5-fluorouracil (5-FU), we compared the gene expression of surgically obtained colorectal cancer specimens with chemosensitivity to 5-FU as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay. Eighty-eight patients with advanced and/or metastatic colorectal cancer provided written informed consent and entered the trial from September 2000 to October 2001. Fresh surgical specimens were used for the MTT assay, and sensitivity to 5-FU was evaluated at a cutoff concentration of 50 μg/ml and 48-h incubation time. Frozen samples were stored at -80°C until mRNA analysis of thymidylate synthetase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP , esnucleoside transporter (NT), and E2F1 by real-time RT-PCR. The correlations between the variables were analyzed, and the predictive value of these mRNAs was assessed statistically using a receiver operating characteristic (ROC) curve. NT and DPD, TP and DPD, and TP and NT mRNA expression levels correlated significantly, while TS and E2F1 showed no correlations. High NT expression was associated with low sensitivity to 5-FU (P<0.013), as were high DPD and E2F1 expression (P<0.022 for both). High TP mRNA expression correlated with low sensitivity to 5-FU (P<0.034), although high TS mRNA expression did not. ROC curves indicated that DPD and NT mRNAs were possible predictors of sensitivity to 5-FU, with cutoff values of 0.6 and 0.4, respectively. The sensitivity of colorectal cancer to 5-FU may be regulated by DPD, the rate-limiting enzyme of catabolism, and NT, an important transmembrane transporter of nucleosides.

AB - To predict the sensitivity of colorectal cancer to 5-fluorouracil (5-FU), we compared the gene expression of surgically obtained colorectal cancer specimens with chemosensitivity to 5-FU as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay. Eighty-eight patients with advanced and/or metastatic colorectal cancer provided written informed consent and entered the trial from September 2000 to October 2001. Fresh surgical specimens were used for the MTT assay, and sensitivity to 5-FU was evaluated at a cutoff concentration of 50 μg/ml and 48-h incubation time. Frozen samples were stored at -80°C until mRNA analysis of thymidylate synthetase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP , esnucleoside transporter (NT), and E2F1 by real-time RT-PCR. The correlations between the variables were analyzed, and the predictive value of these mRNAs was assessed statistically using a receiver operating characteristic (ROC) curve. NT and DPD, TP and DPD, and TP and NT mRNA expression levels correlated significantly, while TS and E2F1 showed no correlations. High NT expression was associated with low sensitivity to 5-FU (P<0.013), as were high DPD and E2F1 expression (P<0.022 for both). High TP mRNA expression correlated with low sensitivity to 5-FU (P<0.034), although high TS mRNA expression did not. ROC curves indicated that DPD and NT mRNAs were possible predictors of sensitivity to 5-FU, with cutoff values of 0.6 and 0.4, respectively. The sensitivity of colorectal cancer to 5-FU may be regulated by DPD, the rate-limiting enzyme of catabolism, and NT, an important transmembrane transporter of nucleosides.

UR - http://www.scopus.com/inward/record.url?scp=0042062300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042062300&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2003.tb01495.x

DO - 10.1111/j.1349-7006.2003.tb01495.x

M3 - Article

VL - 94

SP - 633

EP - 638

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 7

ER -